Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Fractional Er:YAG laser with PRP is more effective and has fewer side effects than microneedling with PRP for vitiligo.

Pranlukast and mirabegron may work as new diabetes drugs.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

PRP speeds up healing with few side effects, but more research is needed to standardize its use.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

New cytokine-targeted therapies show promise for treating alopecia areata.

Ruxolitinib can help regrow hair in severe alopecia areata.

The gelatin/β-TCP scaffold with nanoparticles improves wound healing and skin regeneration.

Platelet-Rich Plasma (PRP) is helpful for skin and hair treatments and works better when combined with other procedures.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

The treatment improved hair color in most vitiligo patients without major side effects.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

PRP effectively reduces hair loss, improves hair quality, and increases hair density.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Platelet- and marrow-derived biologics help heal tissues and reduce infections but need standardized methods for better use.